QuintilesIMS Institute Report: PBMs Reduce Cancer Drug Costs

QuintilesIMS Institute Report: PBMs Reduce Cancer Drug Costs

The growth in the price of cancer medicines in the U.S. averaged 3.6 percent last year, a drop from 4.7 percent in 2015, after accounting for rebates and discounts that drug makers paid to health insurers, according to a new IMS Institute report.